Senior management at CryoCath Technologies (Montreal, Quebec) was elated over the result of an FDA advisory panel meeting last month, despite a list of conditions the company must now address.
Browse by Speciality Area
All Access Subscription
Get unlimited access to our full publication and article library.
Get Access NowInterested in Group Sales? Learn more